BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12900766)

  • 1. Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Sakamoto T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Ishibashi T; Sueishi K
    Gene Ther; 2003 Aug; 10(17):1503-11. PubMed ID: 12900766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
    J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.
    Murakami Y; Ikeda Y; Yonemitsu Y; Onimaru M; Nakagawa K; Kohno R; Miyazaki M; Hisatomi T; Nakamura M; Yabe T; Hasegawa M; Ishibashi T; Sueishi K
    Am J Pathol; 2008 Nov; 173(5):1326-38. PubMed ID: 18845835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.
    Ikeda Y; Goto Y; Yonemitsu Y; Miyazaki M; Sakamoto T; Ishibashi T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K
    Gene Ther; 2003 Jul; 10(14):1161-9. PubMed ID: 12833125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death.
    Imai D; Yoneya S; Gehlbach PL; Wei LL; Mori K
    J Cell Physiol; 2005 Feb; 202(2):570-8. PubMed ID: 15316929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death.
    Cao W; Tombran-Tink J; Chen W; Mrazek D; Elias R; McGinnis JF
    J Neurosci Res; 1999 Sep; 57(6):789-800. PubMed ID: 10467250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
    Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
    Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.
    Tschernutter M; Schlichtenbrede FC; Howe S; Balaggan KS; Munro PM; Bainbridge JW; Thrasher AJ; Smith AJ; Ali RR
    Gene Ther; 2005 Apr; 12(8):694-701. PubMed ID: 15660111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
    Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Murakami Y; Yoshida N; Tabata T; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
    Hum Gene Ther; 2011 May; 22(5):559-65. PubMed ID: 21175295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
    Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer.
    Tomita H; Sugano E; Yawo H; Ishizuka T; Isago H; Narikawa S; Kügler S; Tamai M
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3821-6. PubMed ID: 17652757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor.
    Wu WC; Lai CC; Chen SL; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3480-8. PubMed ID: 12407159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
    Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
    Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
    Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
    J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.
    Murakami Y; Ikeda Y; Yonemitsu Y; Miyazaki M; Inoue M; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2010 Feb; 21(2):199-209. PubMed ID: 19778186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF gene therapy attenuates retinal ischemic injuries in rats.
    Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
    Mol Vis; 2004 Feb; 10():93-102. PubMed ID: 14961006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Jun; 20(6):573-9. PubMed ID: 19257835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.